Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

This data was created as a secondary analysis of MSP Cohort Data (trial registration number NCT02797327). The study protocol can be found doi: 10.1136/bmjopen-2018-023417 and the first description of the cohort profile can be found doi:10.1136/ bmjopen-2020-041631. This cohort aimed to follow Karen and Burmese women from prospectively throughout pregnancy, at delivery and until 3 months post partum with serial high-frequency sampling to assess whole blood transcriptomics and microbiome composition of the gut, vagina and oral cavity, in conjunction with assessment of gene expression and microbial colonisation of gestational tissue. At the time of data deposit samples are still being analyzed but this cohort, the first in marginalized populations to be systematically screened for diabetes on the Thailand Myanmar border was analyzed to review current clinical practice for screening of gestational diabetes mellitus.

Original publication





University of Oxford

Publication Date



Risk-factor-based screening, HAPO trial, Thin-diabetic, Maternal and neonatal anthropometry, MSP Cohort, Symphysis-fundal height measurements, Oral glucose tolerance test, Migrants, Gestational diabetes mellitus